Study On Synergistic Mechanism of Multimodal Combination in Tumor Optical Therapy

Siyu Zhang

doi:10.54097/ngne7e28

Authors

Siyu Zhang

DOI:

https://doi.org/10.54097/ngne7e28

Keywords:

Tumor; Combination Therapy; Synergistic; Photothermal Therapy.

Abstract

With the development of the times, environmental pollution and bad living habits have gradually increased the incidence of cancer in human beings, and the global cancer mortality rate has surged. The treatment of tumor has become a major concern of human beings. Tumor growth and spread are highly heterogeneous, so integrated treatment of cancer has become a new trend. This paper explores the mechanism of multimodal combinations to generate synergistic effects in optical tumor therapy involving combinations of nanocarrier system, chemotherapy, nano platform, photosensitizer, catalyst, immunomodulator and photothermal agent. The results of this paper indicate that combination therapy can break the limitations of single therapy and traditional therapy and realize the synergistic mechanism in treatment. In the face of many difficulties and challenges, combined therapy has great potential and development prospects. It is expected that the optimization and selection of the research program and the clinical application of the combination therapy can get a major breakthrough.

Downloads

Download data is not yet available.

References

[1] Ziliang Zheng,Botao Qu,Xiaorong Yanget al.(2021) Tumor-targeted Pt-Cu-based nanoplatform for near-infrared second window photoacoustic imaging-guided photothermal therapy. Chinese Journal of Inorganic Chemistry, 37(11): 1991-2001.

[2] Jiahui Chen,Tingting Zheng,Xiuyun Zhang, et al. Research Progress on the Application of Near-Infrared Absorbing Inorganic Nanomaterials in Photothermal and Photodynamic Therapy for Tumors [J]. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2396-2414.

[3] Renhui Zhan,Xiaotong Xu,Yuanyuan Cui et al.(2024). Dual-functional nano-carrier system based on NIR-laser-triggered dynamic Au[sbnd]Se interaction for chemo-photothermal synergistic tumor therapy. Colloid and Interface Science Communications100774-.

[4] Chao Li,Zichao Guo,Wenqing Jiaet al.(2025). Gold-Cerium bimetallic Star-Shaped nanoplatform for synergistic tumor therapy with nanozyme Catalytic/Photothermal/Chemotherapy. Journal of Colloid And Interface. Science 753-765.

[5] Yifan Zhao,Tong Qiu,Chige Zhuanget al.(2025). HASc-responsive dual-drug nano-particles for co-delivery of Pt (II) and BAI for combination therapy of tumors. Reactive and Functional Polymers. 106165-106165.

[6] Pengcheng Hu, Xinyi Song,Danlu Zhang, et al.(2025) Construction of multifunctional nanomaterials based on photothermic agents and their synergistic anti-tumor development [J/OL]. Bioprocessing,1-15

[7] Bo Hu, Fanpeng Kong, Xiaonan Gao et al. (2018). Avoiding Thiol Compound Interference: A Nanoplatform Based on High-Fidelity Au-Se Bonds for Biological Applications. Angewandte Chemie (International ed. in English) (19),5306-5309.

[8] Sudhakar Reddy Baddam,Srinivas Ganta,Seshadri Nalla et al.(2024).Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment. International journal of pharmaceutics124346-124346.

[9] So Jae Young,Ohm Joyce,Lipkowitz Stan et al.(2022).Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options . Pharmacology & therapeutics108253-108253.

[10] Xiang Wang,Xinxin Ren,Xu Lin et al.(2024).Recent progress of ferroptosis in cancers and drug discovery. Asian Journal of Pharmaceutical Sciences(4),100939-100939.

[11] Stockwell Brent R. (2022). Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell (14),2401-2421.

[12] Tianjiao Zhou,Mengmeng Zhang et al. (2023). Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer. Biomaterials122447-122447.

[13] Maowei Ni, Jie Zhou, Zhihui Zhu et al.(2023). Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2+ accumulation. Phytomedicine154701-154701.

[14] Weikang Guo, Wanyue Wang, Fei Lei et al.(2024). Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie116680-116680.

[15] Siyuan Wang, Xuqing Li, Junet Li al. (2023). Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury. Chemico-biological interactions110825-110825.

[16] Lijia Jing, Xiaolong Liang, Zijian Deng et al. (2014). Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials(22),5814-5821.

[17] Linping Zhao, Rongrong Zheng, Huaqing Chen, et al. (2020). Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy. [J]. Nano letters, 20(3):2062-2071.

[18] Zuhong Li, Yangjun Chen, Ya Yanget al. (2019). Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment. Frontiers in bioengineering and biotechnology 293.

[19] Zhichao Hu, Xue Zhou, Wei Zhanget al.(2025). High-entropy oxide nanozyme for T1/T2 dual-mode magnetic resonance imaging guided photothermal-nanocatalytic tumor therapy. Journal of Colloid And Interface Science 325-334.

[20] Deqiu Huang,Tong Wu,Siyuan Lan,Chengkuan Liu,Zhouyi Guo & Wen Zhang.(2022).In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors.Biomaterials121808-121808..